PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33006225-7	2020	Ews and Parp1 double mutant mice do not show improved survival, but supplementation with nicotinamide mononucleotides extends Ews-mutant pups" survival, which might be due to compensatory activation of other PARP proteins.	Nicotinamide Mononucleotide	89-117	poly(ADP-ribose) polymerase 1	Homo sapiens	208-212	
30661231-7	2019	However, NMN treatment demonstrates to be a promising candidate as a therapeutic approach due to its multi-targeted effect acting as PARP1 and CD38 inhibitor, sirtuins activator, mitochondrial fission inhibitor, and NAD+ supplement.	Nicotinamide Mononucleotide	9-12	poly(ADP-ribose) polymerase 1	Homo sapiens	133-138